18.03.2020 - 26.03.2020 The 5th Annual Migraine World Summit
The Migraine World Summit (MWS) is an annual virtual conference held in March and streamed online, free of charge. At the summit, leading migraine experts, doctors, and specialists from around the world are interviewed to address the latest in migraine research and management.
This year, the event ran from 18–26 March, featuring 4–5 daily interviews with over 30 of the world's leading migraine experts and specialists, as well as patient advocates. During the “Causes & diagnosis” session on Day 2, Prof. Lyn Griffiths (Professor and Executive Director of the Institute of Health and Biomedical Innovation, Queensland University of Technology) was interviewed about recent advances in genetics and migraine. Regarding migraine “Types,” Dr. Patricia Pozo Rosich (Director of Headache and Neurological Pain Research, Vall d’Hebron Institute of Research) explored topics about pain in the migraine brain on Day 3. During Day 5 regarding “Triggers,” Dr. Vincent Martin (Director of the Headache and Facial Pain Center, University of Cincinnati Gardner Neuroscience Institute) answered questions regarding evidence-based research about migraine triggers. Day 8 saw Prof. Paul Martin (Professor and Director of the Research School of Psychology, Australian National University), who elaborated on the importance of considering psychological comorbidities and applying it to patient care in the “Taking control” session.
A plethora of additional sessions included Dr. Gretchen Tietjen (Professor and Chair of Neurology, University of Toledo) discussing links between trauma and migraine, Dr. Peter Goadsby (Professor of Neurology and Headache Specialist, King's College London) explaining the latest innovative migraine treatments, and Dr. Shivang Joshi (Associate Professor of Clinical Pharmacy Practice and Headache Specialist, University of Buffalo School of Pharmacy) answering questions on topics like aging with migraine and late-onset migraine. Several patient advocates also gave powerful accounts of their experiences as migraineurs, and emphasized how valuable MWS is to promote advocacy and connections between healthcare professionals, research scientists, patients, and their supporters.
Click here to find more information about MWS 2020.
